Comments: NJ S301 | 2022-2023 | Regular Session

Bill Title: Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.

Sponsorship: Partisan Bill (Democrat 8)

Status: (Introduced - Dead) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee [S301 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey S301 at this time.

feedback